MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast of Mastercard Incorporated Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Mastercard Incorporated MA at this time. Stock is rising and might rise more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Mastercard Incorporated is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Mastercard Incorporated stays above 526.7, but if it comes below 526.7, then a intra day sell could be more profitable.
If you take a sell trade below 526.7, then use 526.7 as stoploss and 518.45 as target. However if you take a buy trade in Mastercard Incorporated, then use 526.7 as stoploss and 536.7 as target.
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Stock market update: Nifty Pharma index 0.61% The Nifty Pharma index closed 0.61 per cent at 21828.60. - NEWS as on 2024-11-27 indiatimes.com
Stock market update: Nifty Pharma index 0.97% The Nifty Pharma index closed 0.97 per cent at 21961.75. - NEWS as on 2024-11-26 indiatimes.com
Stock market update: Nifty Pharma index 0.98% The Nifty Pharma index closed 0.98 per cent at 22177.05. - NEWS as on 2024-11-25 indiatimes.com
JioCinema faces technical glitch during IPL 2025 mega auction live stream; alternative ways to watch JioCinema, the official streaming partner for the IPL 2025 Mega Auction, experienced technical difficulties during the event, leaving many users unable to access the live stream. Fans took to social media to express their frustration, sharing screenshots o - NEWS as on 2024-11-24 indiatimes.com
Aurobindo joins hands with global pharma player to develop respiratory products Aurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collaboration involves a shared cost of up to million over three to five years, with both companies sharing marketing righ - NEWS as on 2024-11-23 indiatimes.com
Stock market update: Nifty Pharma index 1.02% The Nifty Pharma index closed 1.02 per cent at 21962.05. - NEWS as on 2024-11-22 indiatimes.com
Stock market update: Nifty Pharma index 0.13% The Nifty Pharma index closed 0.13 per cent at 21740.10. - NEWS as on 2024-11-21 indiatimes.com
Shankar Sharma flags CLSA India note as "trap" amid market optimism Market expert Shankar Sharma issued a cautionary note to Indian investors, criticizing a recent report from global brokerage firm CLSA that shifted its investment focus from China to India. In a post on X (formerly Twitter), Sharma labeled the report as a - NEWS as on 2024-11-20 indiatimes.com
Stock market update: Nifty Pharma index 1.04% The Nifty Pharma index closed 1.04 per cent at 21768.85. - NEWS as on 2024-11-19 indiatimes.com
MFs buy renewables, cement and pharma in October Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They invested in renewable energy companies due to increasing electricity demand and government initiatives. Anticipating a rise in g - NEWS as on 2024-11-15 indiatimes.com
Stock market update: Nifty Pharma index 0.26% The Nifty Pharma index closed 0.26 per cent at 21752.00. - NEWS as on 2024-11-14 indiatimes.com
AstraZeneca Pharma Q2 Results: Net profit falls 27% to Rs 38 crore AstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on September 30, 2024. The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal. - NEWS as on 2024-11-13 indiatimes.com
Pharma market sees 6.1% growth in October despite subdued volumes Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipi - NEWS as on 2024-11-12 indiatimes.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 26 Tue Nov 2024 | 528.48 | 525.06 to 530.65 | 0.36% | 0.82 times |
| 25 Mon Nov 2024 | 526.60 | 521.02 to 528.25 | 1.1% | 1.58 times |
| 22 Fri Nov 2024 | 520.86 | 516.18 to 521.71 | 1.12% | 1.1 times |
| 21 Thu Nov 2024 | 515.10 | 511.58 to 520.12 | 0.5% | 1.08 times |
| 20 Wed Nov 2024 | 512.54 | 511.00 to 522.50 | -1.33% | 0.85 times |
| 19 Tue Nov 2024 | 519.46 | 516.76 to 522.65 | -0.42% | 0.95 times |
| 18 Mon Nov 2024 | 521.63 | 517.00 to 523.49 | -0.05% | 0.88 times |
| 15 Fri Nov 2024 | 521.89 | 518.00 to 523.39 | 0.29% | 0.85 times |
| 14 Thu Nov 2024 | 520.40 | 517.65 to 522.36 | -0.28% | 0.87 times |
| 13 Wed Nov 2024 | 521.88 | 516.42 to 530.50 | -1.38% | 0.94 times |
| 12 Tue Nov 2024 | 529.17 | 527.30 to 530.90 | -0.18% | 0.91 times |
| 11 Mon Nov 2024 | 530.12 | 528.52 to 534.03 | 1.02% | 0.78 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance